Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AmaNtadine for NeuroenhancEment in acutE patients Study
2024-512333-33-00Phase 2Completed
- Sponsor
- University Hospital Tübingen
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of amantadine in vegetative state (VS), sponsored by University Hospital Tübingen. Primary endpoint: Responder rate by GCS at day 5. Started Mar 2024; status: completed.
02
Drugs
amantadine
03
Conditions
vegetative state (VS)
Beyond the preview
Go deeper on 2024-512333-33-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-512333-33-00.